Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04591015 · ClinicalTrials.gov registry record · NA

Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19

A NA study, sponsored by Scripps Whittier Diabetes Institute.

Completed
Registry status
NA
Development phase
172
Enrollment target

NCT04591015 is a NA study that has completed, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 172 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04591015, a NA study, has completed, sponsored by Scripps Whittier Diabetes Institute.

COMPLETED
Registry status
NA
Development phase
172 participants
Enrollment target

Study Summary

The COVID-19 pandemic has triggered extremely high hospitalization rates where mitigation strategies are urgently necessary to aid vulnerable Hispanic and Latino populations who are experiencing health disparities as well as high type 2 diabetes (T2D) prevalence with poor clinical outcomes when compared to non-Hispanic populations. The supplemental Dulce Digital-COVID Aware (DD-CA) intervention addresses specific barriers in diverse underserved Hispanic and Latino communities to improve glucose control and lower transmission of COVID-19 during a highly vulnerable period post hospitalization discharge, to reduce hospital readmission rates. This supplement will integrate COVID educational messaging with glucose management messaging within a low-cost, easily adoptable digital texting platform and offer critical information in a culturally and linguistically relevant manner to address specific barriers in diverse underserved communities.

Interventions

  • BEHAVIORAL Hospital: DD-CA
  • BEHAVIORAL Hospital: Usual Care (UC)

Trial Details

FieldValue
Enrollment Target 172 participants
Start Date 2021-02-01
Est. Completion 2022-08-31
Phase NA

What the Registry Record Tells You About NCT04591015

The ClinicalTrials.gov registry entry for NCT04591015 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Whittier Diabetes Institute, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Hospital: DD-CA is the first listed.

NCT04591015 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04591015 about?

NCT04591015 is a clinical study titled "Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19". The COVID-19 pandemic has triggered extremely high hospitalization rates where mitigation strategies are urgently necessary to aid vulnerable Hispanic and Latino populations who are experiencing health disparities as well as high type 2 diabetes (T2D) prevalence with poor clinical outcomes when comp...

What is the current status of trial NCT04591015?

This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2021-02-01. Estimated completion is 2022-08-31.

What interventions are being tested in trial NCT04591015?

The interventions under investigation include: Hospital: DD-CA (BEHAVIORAL), Hospital: Usual Care (UC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04591015?

This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.